• 15014 Citations
  • 65 h-Index
1990 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1990 2019

  • 15014 Citations
  • 65 h-Index
  • 341 Article
  • 3 Chapter
  • 2 Review article
2019

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

on behalf of the “Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup), Jan 1 2019, In : Hematological Oncology.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Virus Diseases
Hepacivirus
Multicenter Studies
Lymphoma

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

Rattotti, S., Ferretti, V. V., Rusconi, C., Rossi, A., Fogazzi, S., Baldini, L., Pioltelli, P., Balzarotti, M., Farina, L., Ferreri, A. J. M., Laszlo, D., Speziale, V., Varettoni, M., Sciarra, R., Morello, L., Tedeschi, A., Frigeni, M., Defrancesco, I., Zerbi, C., Flospergher, E. & 4 others, Nizzoli, M. E., Morra, E., Arcaini, L. & Workgroup), O. B. O. T. R. E. L. REL. . H. C. N. O. L. . L., 2019, In : Hematological Oncology. 37, 2, p. 160-167

Research output: Contribution to journalArticle

2018

Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphoma

Citterio, G., Calimeri, T. & Ferreri, AJM., 2018, In : Expert Review of Neurotherapeutics. 18, 5, p. 379-393 15 p.

Research output: Contribution to journalArticle

Lymphoma
Central Nervous System
Therapeutics
Combination Drug Therapy
PubMed

Clarithromycin as a "repurposing drug" against MALT lymphoma

Ferreri, AJM., Cecchetti, C., Kiesewetter, B., Sassone, M., Calimeri, T., Perrone, S., Ponzoni, M. & Raderer, M., 2018, In : British Journal of Haematology. 182, 6, p. 913-915 3 p.

Research output: Contribution to journalArticle

Drug Repositioning
Marginal Zone B-Cell Lymphoma
Clarithromycin

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma

Wang, X., Cao, X., Sun, R., Tang, C., Tzankov, A., Zhang, J., Manyam, GC., Xiao, M., Miao, Y., Jabbar, K., Tan, X., Pang, Y., Visco, C., Xie, Y., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, KL. & 16 others, Hsi, ED., Choi, WWL., van Krieken, JH., Huh, J., Ponzoni, M., Ferreri, AJM., Møller, MB., Parsons, BM., Winter, JN., Piris, MA., Li, S., Miranda, RN., Medeiros, LJ., Li, Y., Xu-Monette, ZY. & Young, KH., 2018, In : Neoplasia (United States). 20, 6, p. 574-593 20 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Sequence Deletion
Survival
PTEN Phosphohydrolase
Messenger RNA

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy

Yao, Z., Deng, L., Xu-Monette, ZY., Manyam, GC., Jain, P., Tzankov, A., Visco, C., Bhagat, G., Wang, J., Dybkaer, K., Tam, W., Hsi, ED., van Krieken, JH., Ponzoni, M., Ferreri, AJM., Møller, MB., Winter, JN., Piris, MA., Fayad, L., Liu, Y. & 7 others, Song, Y., Orlowski, RZ., Kantarjian, H., Medeiros, LJ., Li, Y., Cortes, J. & Young, KH., 2018, In : Leukemia. 32, 2, p. 353-363 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Immunotherapy
Bone Marrow
Bone Marrow Diseases
Survival
29 Citations (Scopus)

Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mule, A., Picardi, M., Romano, A., Cantonetti, M., Nasa, G. L., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, A. J. M., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, A. M. & Rambaldi, A., Feb 10 2018, In : Journal of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Disease-Free Survival
Vincristine
Doxorubicin

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mulé, A., Picardi, M., Romano, A., Cantonetti, M., La Nasa, G., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, A. J. M., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, A. M. & Rambaldi, A., Feb 10 2018, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Disease-Free Survival
Vincristine
Doxorubicin

Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mule, A., Picardi, M., Romano, A., Cantonetti, M., Nasa, G. L., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, A. J. M., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, A. M. & Rambaldi, A., 2018, In : Journal of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Disease-Free Survival
Vincristine
Doxorubicin

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mulé, A., Picardi, M., Romano, A., Cantonetti, M., La Nasa, G., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, AJM., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, AM. & Rambaldi, A., 2018, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Disease-Free Survival
Vincristine
Doxorubicin

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Iannitto, E., Bellei, M., Amorim, S., Ferreri, A. J. M., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse-Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, A. M., Merli, M. & 11 others, Gini, G., Cabras, M. G., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M. & Thieblemont, C., Dec 2018, In : British Journal of Haematology. 183, 5, p. 755-765 11 p.

Research output: Contribution to journalArticle

Lymphoma
Confidence Intervals
Febrile Neutropenia
Splenectomy
Infection
1 Citation (Scopus)

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Iannitto, E., Bellei, M., Amorim, S., Ferreri, A. J. M., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse-Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, A. M., Merli, M. & 11 others, Gini, G., Cabras, M. G., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M. & Thieblemont, C., 2018, In : British Journal of Haematology. 183, 5, p. 755-765 11 p.

Research output: Contribution to journalArticle

Lymphoma
Confidence Intervals
Febrile Neutropenia
Splenectomy
Infection

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Iannitto, E., Bellei, M., Amorim, S., Ferreri, AJM., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse-Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, AM., Merli, M. & 11 others, Gini, G., Cabras, MG., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M. & Thieblemont, C., 2018, In : British Journal of Haematology. 183, 5, p. 755-765 11 p.

Research output: Contribution to journalArticle

Lymphoma
Confidence Intervals
Febrile Neutropenia
Splenectomy
Infection
14 Citations (Scopus)

ESMO Consensus Conference on malignant lymphoma: General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

& the ESMO Lymphoma Consensus Conference Panel Members, Mar 1 2018, In : Annals of Oncology. 29, 3, p. 544-562 19 p.

Research output: Contribution to journalArticle

Medical Oncology
Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Peripheral T-Cell Lymphoma
Literature

ESMO consensus conference on Malignant lymphoma: Management of ‘ultra-high-risk’ patients

Hutchings, M., Ladetto, M., Buske, C., De Nully Brown, P., Ferreri, AJM., Pfreundschuh, M., Schmitz, N., Sureda Balari, A., Van Imhoff, G., Walewski, J. & Members, T. ESMO. L. C. C. P., 2018, In : Annals of Oncology. 29, 8, p. 1687-1700 14 p.

Research output: Contribution to journalArticle

Medical Oncology
Lymphoma
Literature
Lymphoma, Large B-Cell, Diffuse
Switzerland
27 Citations (Scopus)

Long-Term results of the FOLL05 trial comparing R-CVP Versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage symptomatic follicular lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, A. J. M., Vallisa, D., Marcheselli, L. & Federico, M., Mar 1 2018, In : Journal of Clinical Oncology. 36, 7, p. 689-696 8 p.

Research output: Contribution to journalArticle

Mitoxantrone
Follicular Lymphoma
Vincristine
Prednisone
Cyclophosphamide

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, AJM., Vallisa, D., Marcheselli, L. & Federico, M., 2018, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36, 7, p. 689-696 8 p.

Research output: Contribution to journalArticle

Mitoxantrone
Follicular Lymphoma
Vincristine
Prednisone
Cyclophosphamide

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, A. J. M., Vallisa, D., Marcheselli, L. & Federico, M., Mar 1 2018, In : Journal of Clinical Oncology. 36, 7, p. 689-696 8 p.

Research output: Contribution to journalArticle

Mitoxantrone
Follicular Lymphoma
Vincristine
Prednisone
Cyclophosphamide

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma

Ceriani, L., Milan, L., Martelli, M., Ferreri, AJM., Cascione, L., Zinzani, PL., Di Rocco, A., Conconi, A., Stathis, A., Cavalli, F., Bellei, M., Cozens, K., Porro, E., Giovanella, L., Johnson, PW. & Zucca, E., 2018, In : Blood. 132, 2, p. 179-186 8 p.

Research output: Contribution to journalArticle

Computerized tomography
Fluorodeoxyglucose F18
B-Cell Lymphoma
Tumors
Cells

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, AJM., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, EA., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stroke Volume
Comorbidity
Preexisting Condition Coverage
Left Ventricular Hypertrophy

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., Feb 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Comorbidity
Stroke Volume
Doxorubicin
Preexisting Condition Coverage

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., Feb 1 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stroke Volume
Comorbidity
Preexisting Condition Coverage
Left Ventricular Hypertrophy

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

El-Galaly, TC., Cheah, CY., Bendtsen, MD., Nowakowski, GS., Kansara, R., Savage, KJ., Connors, JM., Sehn, LH., Goldschmidt, N., Shaulov, A., Farooq, U., Link, BK., Ferreri, AJM., Calimeri, T., Cecchetti, C., Dann, EJ., Thompson, CA., Inbar, T., Maurer, MJ., Gade, IL. & 14 others, Juul, MB., Hansen, JW., Holmberg, S., Larsen, TS., Cordua, S., Mikhaeel, NG., Hutchings, M., Seymour, JF., Clausen, MR., Smith, D., Opat, S., Gilbertson, M., Thanarajasingam, G. & Villa, D., 2018, In : European Journal of Cancer. 93, 4, p. 57-68 12 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Survival
Methotrexate
Recurrence
Status Epilepticus
2017
15 Citations (Scopus)

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma

Wang, J., Xu-Monette, ZY., Jabbar, KJ., Shen, Q., Manyam, GC., Tzankov, A., Visco, C., Montes-Moreno, S., Dybkær, K., Tam, W., Bhagat, G., Hsi, ED., van Krieken, JH., Ponzoni, M., Ferreri, AJM., Wang, S., Møller, MB., Piris, MA., Medeiros, LJ., Li, Y. & 2 others, Pham, LV. & Young, KH., 2017, In : American Journal of Pathology. 187, 8, p. 1700-1716 17 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Phosphatidylinositol 3-Kinase
MicroRNAs
Cell Survival
Therapeutics
8 Citations (Scopus)

Bacteria associated with marginal zone lymphomas

Ponzoni, M. & Ferreri, AJM., 2017, In : Best Practice and Research: Clinical Haematology. 30, 1-2, p. 32-40 9 p.

Research output: Contribution to journalArticle

Marginal Zone B-Cell Lymphoma
Lymphoma
Bacteria
Achromobacter denitrificans
Chlamydophila psittaci
31 Citations (Scopus)

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Guillermo, A. L., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, A. J. M., Zachée, P., Bosly, A. & 11 others, Haioun, C., Stelitano, C., Bellei, M., Ponzoni, M., Moreau, A., Jack, A., Campo, E., Mazzucchelli, L., Cavalli, F., Johnson, P. & Thieblemont, C., Jun 10 2017, In : Journal of Clinical Oncology. 35, 17, p. 1905-1912 8 p.

Research output: Contribution to journalArticle

Chlorambucil
Marginal Zone B-Cell Lymphoma
Disease-Free Survival
Appointments and Schedules
Survival
31 Citations (Scopus)

Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Lopez Guillermo, A., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, A. J., Zachée, P., Bosly, A. & 11 others, Haioun, C., Stelitano, C., Bellei, M., Ponzoni, M., Moreau, A., Jack, A., Campo, E., Mazzucchelli, L., Cavalli, F., Johnson, P. & Thieblemont, C., 2017, In : Journal of Clinical Oncology. 35, 17, p. 1905-1912 8 p.

Research output: Contribution to journalArticle

31 Citations (Scopus)

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Guillermo, AL., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, AJM., Zachée, P., Bosly, A. & 11 others, Haioun, C., Stelitano, C., Bellei, M., Ponzoni, M., Moreau, A., Jack, A., Campo, E., Mazzucchelli, L., Cavalli, F., Johnson, P. & Thieblemont, C., 2017, In : Journal of Clinical Oncology. 35, 17, p. 1905-1912 8 p.

Research output: Contribution to journalArticle

Chlorambucil
Marginal Zone B-Cell Lymphoma
Disease-Free Survival
Appointments and Schedules
Survival
5 Citations (Scopus)

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

Visco, C., Wang, J., Tisi, MC., Deng, L., d'Amore, E. S. G., Tzankov, A., Montes-Moreno, S., Dybkær, K., Bhagat, G., Hsi, ED., Van Krieken, JH., Ponzoni, M., Ferreri, AJM., Møller, MB., Piris, MA., Medeiros, LJ., Xu-Monette, ZY. & Young, KH., 2017, In : British Journal of Cancer. 117, 11, p. 1685-1688 4 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Hepacivirus
Non-Hodgkin's Lymphoma
Gene Expression Profiling
B-Cell Lymphoma
17 Citations (Scopus)

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial

Ferreri, A. J. M., Sassone, M., Zaja, F., Re, A., Spina, M., Rocco, A. D., Fabbri, A., Stelitano, C., Frezzato, M., Rusconi, C., Zambello, R., Couto, S., Ren, Y., Arcari, A., Bertoldero, G., Nonis, A., Scarfò, L., Calimeri, T., Cecchetti, C., Chiozzotto, M. & 2 others, Govi, S. & Ponzoni, M., Mar 1 2017, In : The Lancet Haematology. 4, 3, p. e137-e146 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stem Cell Transplantation
Maintenance
Recurrence
lenalidomide
17 Citations (Scopus)

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial

Ferreri, A. J. M., Sassone, M., Zaja, F., Re, A., Spina, M., Rocco, A. D., Fabbri, A., Stelitano, C., Frezzato, M., Rusconi, C., Zambello, R., Couto, S., Ren, Y., Arcari, A., Bertoldero, G., Nonis, A., Scarfò, L., Calimeri, T., Cecchetti, C., Chiozzotto, M. & 2 others, Govi, S. & Ponzoni, M., Mar 1 2017, In : The Lancet Haematology. 4, 3, p. e137-e146

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stem Cell Transplantation
Maintenance
Recurrence
lenalidomide
17 Citations (Scopus)

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial

Ferreri, AJM., Sassone, M., Zaja, F., Re, A., Spina, M., Rocco, AD., Fabbri, A., Stelitano, C., Frezzato, M., Rusconi, C., Zambello, R., Couto, S., Ren, Y., Arcari, A., Bertoldero, G., Nonis, A., Scarfò, L., Calimeri, T., Cecchetti, C., Chiozzotto, M. & 2 others, Govi, S. & Ponzoni, M., 2017, In : The Lancet Haematology. 4, 3, p. e137-e146

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stem Cell Transplantation
Maintenance
Recurrence
lenalidomide
27 Citations (Scopus)

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, A. J. M., Vallisa, D., Marcheselli, L. & Federico, M., Nov 2 2017, In : Journal of Clinical Oncology. p. JCO2017741652

Research output: Contribution to journalArticle

Mitoxantrone
Follicular Lymphoma
Vincristine
Prednisone
Cyclophosphamide
27 Citations (Scopus)

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, A. J. M., Vallisa, D., Marcheselli, L. & Federico, M., Nov 2 2017, In : Journal of Clinical Oncology. p. JCO2017741652

Research output: Contribution to journalArticle

Mitoxantrone
Follicular Lymphoma
Vincristine
Prednisone
Cyclophosphamide
27 Citations (Scopus)

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, A. J. M., Vallisa, D., Marcheselli, L. & Federico, M., Nov 2 2017, In : Journal of Clinical Oncology. 36, 7, p. 689-696 8 p.

Research output: Contribution to journalArticle

Mitoxantrone
Follicular Lymphoma
Vincristine
Prednisone
Cyclophosphamide
13 Citations (Scopus)

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

Xia, Y., Xu-Monette, ZY., Tzankov, A., Li, X., Manyam, GC., Murty, V., Bhagat, G., Zhang, S., Pasqualucci, L., Visco, C., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Richards, KL., Hsi, ED., Choi, WW., van Krieken, JH., Huh, J., Ponzoni, M. & 13 others, Ferreri, AJ., Møller, MB., Parsons, BM., Winter, JN., Piris, MA., Westin, J., Fowler, N., Miranda, RN., Ok, CY., Li, Y., Li, J., Medeiros, LJ. & Young, KH., 2017, In : Leukemia. 31, 3, p. 625-636 12 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Sequence Deletion
Plasma Cells
Cell Differentiation
8 Citations (Scopus)

Lymphoblastic lymphoma

Cortelazzo, S., Ferreri, A., Hoelzer, D. & Ponzoni, M., 2017, In : Critical Reviews in Oncology/Hematology. 113, 4, p. 304-317 14 p.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
T-Lymphocytes
B-Lymphoid Precursor Cells
Cell Lineage
Lymphoma
26 Citations (Scopus)

m-TOR inhibitors and their potential role in haematological malignancies

Calimeri, T. & Ferreri, AJM., 2017, In : British Journal of Haematology. 177, 5, p. 684-702 19 p.

Research output: Contribution to journalArticle

Hematologic Neoplasms
Sirolimus
Phosphatidylinositol 3-Kinases
Waldenstrom Macroglobulinemia
Proxy
9 Citations (Scopus)

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., May 17 2017, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stroke Volume
Comorbidity
Preexisting Condition Coverage
Left Ventricular Hypertrophy
9 Citations (Scopus)

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., May 19 2017, In : Hematological Oncology.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stroke Volume
Comorbidity
Preexisting Condition Coverage
Left Ventricular Hypertrophy
12 Citations (Scopus)
Chemotherapy
Tumors
Lymphoma
Anti-Bacterial Agents
Costs
10 Citations (Scopus)

Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma

Ceriani, L., Martelli, M., Gospodarowicz, MK., Ricardi, U., Ferreri, AJ., Chiappella, A., Stelitano, C., Balzarotti, M., Cabrera, ME., Cunningham, D., Guarini, A., Zinzani, PL., Giovanella, L., Johnson, PW. & Zucca, E., 2017, In : International Journal of Radiation Oncology Biology Physics. 97, 1, p. 42-49 8 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
positrons
tomography
irradiation
progressions
10 Citations (Scopus)

Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma

Ceriani, L., Martelli, M., Gospodarowicz, M. K., Ricardi, U., Ferreri, A. J. M., Chiappella, A., Stelitano, C., Balzarotti, M., Cabrera, M. E., Cunningham, D., Guarini, A., Zinzani, P. L., Giovanella, L., Johnson, P. W. M. & Zucca, E., Jan 1 2017, In : International Journal of Radiation Oncology Biology Physics. 97, 1, p. 42-49 8 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
positrons
tomography
irradiation
progressions
17 Citations (Scopus)

Primary central nervous system lymphoma

Citterio, G., Reni, M., Gatta, G. & Ferreri, AJM., 2017, In : Critical Reviews in Oncology/Hematology. 113, 4, p. 97-110 14 p.

Research output: Contribution to journalArticle

Lymphoma
Central Nervous System
Thiotepa
Remission Induction
Drug Therapy
17 Citations (Scopus)

Primary central nervous system lymphoma

Citterio, G., Reni, M., Gatta, G. & Ferreri, A. J. M., May 1 2017, In : Critical Reviews in Oncology/Hematology. 113, p. 97-110 14 p.

Research output: Contribution to journalReview article

Lymphoma
Central Nervous System
Thiotepa
Remission Induction
Drug Therapy
13 Citations (Scopus)

Primary mediastinal large B-cell lymphoma

Martelli, M., Ferreri, A., Di Rocco, A., Ansuinelli, M. & Johnson, PWM., 2017, In : Critical Reviews in Oncology/Hematology. 113, 8, p. 318-327 10 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Radiotherapy
Sclerosis
B-Lymphocytes
Prospective Studies
6 Citations (Scopus)

Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study

Ceriani, L., Martelli, M., Conconi, A., Zinzani, PL., Ferreri, AJM., Botto, B., Stelitano, C., Gotti, M., Cabras, MG., Rigacci, L., Giovanella, L., Zucca, E. & Johnson, PWM., 2017, In : British Journal of Haematology. 178, 4, p. 588-591 4 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Glycolysis
Positron-Emission Tomography
Lymphoma
Nuclear Family
6 Citations (Scopus)

Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study

Ceriani, L., Martelli, M., Conconi, A., Zinzani, P. L., Ferreri, A. J. M., Botto, B., Stelitano, C., Gotti, M., Cabras, M. G., Rigacci, L., Giovanella, L., Zucca, E. & Johnson, P. W. M., Aug 1 2017, In : British Journal of Haematology. 178, 4, p. 588-591 4 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Glycolysis
Positron-Emission Tomography
Lymphoma
Disease-Free Survival
8 Citations (Scopus)
Lymphoma
Central Nervous System
Radiation
Therapeutics
Methotrexate